Micardis and Viread drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Micardis (telmisartan) and Viread (tenofovir disoproxil fumarate). Common drug interactions include cardiomegaly among females and drug eruption among males.

The phase IV clinical study analyzes what interactions people have when they take Micardis and Viread. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Micardis?

Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.

What is Viread?

Viread has active ingredients of tenofovir disoproxil fumarate. It is often used in hepatitis b. eHealthMe is studying from 51,542 Viread users. Check the latest studies of Viread.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

17 people who take Micardis and Viread together, and have interactions are studied.

Micardis and Viread drug interactions.

What are the common drug interactions of Micardis and Viread, by gender? *:

female:

  1. Cardiomegaly (increased size of heart than normal)
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  3. Neonatal respiratory distress syndrome (a serious medical condition where a newborn baby's lungs cannot provide their body with enough oxygen)
  4. Premature baby
  5. Albuminuria (albumin is present in the urine)
  6. Anaemia (lack of blood)
  7. Blood alkaline phosphatase increased
  8. Blood urea decreased
  9. Live birth
  10. Maternal exposure during pregnancy (use of substance during pregnancy)

male:

  1. Drug eruption (adverse drug reaction of the skin)
  2. Dyslipidaemia (abnormal amount of lipids)
  3. Emotional distress
  4. Pain
  5. Renal failure (kidney dysfunction)
  6. Haemorrhage (bleeding)
  7. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  8. Insomnia (sleeplessness)
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Anxiety

What are the common drug interactions of Micardis and Viread, by age (0-1 to 60+)? *:

0-1:

  1. Cardiomegaly (increased size of heart than normal)
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  3. Neonatal respiratory distress syndrome (a serious medical condition where a newborn baby's lungs cannot provide their body with enough oxygen)
  4. Premature baby

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Albuminuria (albumin is present in the urine)
  2. Anaemia (lack of blood)
  3. Blood alkaline phosphatase increased
  4. Blood urea decreased
  5. Live birth
  6. Maternal exposure during pregnancy (use of substance during pregnancy)
  7. Premature delivery
  8. Proteinuria (presence of protein in the urine)
  9. Uterine disorder

40-49:

  1. Drug eruption (adverse drug reaction of the skin)
  2. Dyslipidaemia (abnormal amount of lipids)
  3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  4. Insomnia (sleeplessness)
  5. Aphthous stomatitis (mouth ulcer)
  6. Diarrhoea

50-59:

  1. Pain
  2. Renal failure (kidney dysfunction)
  3. Haemorrhage (bleeding)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Bone density decreased
  7. Chronic kidney disease
  8. Emotional distress

60+:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)
  5. Renal injury (kidney injury)

What are the existing conditions these people have? *

  1. Hiv Infection: 8 people, 47.06%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 17.65%
  3. Dyslipidaemia (abnormal amount of lipids): 3 people, 17.65%
  4. Drug Eruption (adverse drug reaction of the skin): 3 people, 17.65%
  5. Pain: 2 people, 11.76%
  6. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 2 people, 11.76%
  7. High Blood Cholesterol: 2 people, 11.76%
  8. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 11.76%
  9. Depression: 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Micardis and Viread?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Micardis and Viread:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micardis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Viread:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micardis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viread and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on telmisartan and tenofovir disoproxil fumarate (the active ingredients of Micardis and Viread, respectively), and Micardis and Viread (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: